🏛️ Verified NIH Record • Updated 2026-02-20
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology (NCT06207032)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Tempus AI
🩺 Plain-English Summary (8th-Grade Level)
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Who can join: Review the eligibility criteria below.
Location: Alabama Oncology — Birmingham, Alabama
Age range: 18 Years to 99 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (32 Sites)
Showing the first 25 of 32 sites.
- Alabama Oncology — Birmingham, Alabama
- PIH Health Whittier Hospital & PIH Health Physicians — Whittier, California
- Eastern CT and Hematology and Oncology Associates — Norwich, Connecticut
- Cancer Specialists of North Florida — Jacksonville, Florida
- Morehouse — Atlanta, Georgia
- Piedmont Healthcare — Atlanta, Georgia
- Southern Illinois Healthcare — Carterville, Illinois
- Hope and Healing Cancer Services — Hinsdale, Illinois
- Cancer Care Specialists of Illinois — O'Fallon, Illinois
- Illinois Cancer Care — Peoria, Illinois
- Northwest Oncology and Hematology — Rolling Meadows, Illinois
- Fort Wayne — Fort Wayne, Indiana
- Goshen Center for Cancer Care — Goshen, Indiana
- St. Claire Healthcare — Morehead, Kentucky
- Frederick Health Regional System — Frederick, Maryland
- Southcoast Centers for Cancer Care — Fairhaven, Massachusetts
- Hannibal Regional Healthcare System, Inc. — Hannibal, Missouri
- Lake Regional Health — Osage Beach, Missouri
- Mosaic Life Care — Saint Joseph, Missouri
- Oncology Hematology Associates — Springfield, Missouri
- Hope Cancer Care of Nevada — Las Vegas, Nevada
- Cancer Care Specialists - Reno — Reno, Nevada
- New Jersey Cancer Center — Belleville, New Jersey
- Regional Cancer Care Associates — Belleville, New Jersey
- Hematology Oncology Associates of Central NY — East Syracuse, New York
📞 Contact the Study Coordinator
Phone: (800) 739-4137
Email: aries@tempus.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cancer
- Ovarian Tissue Cryopreservation in Children — Rochester, Minnesota
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study — Aurora, Colorado
- Ex Onc SLED: A Study Utilizing A Weighted Sled for Horizontal Resistance Training — Pittsburgh, Pennsylvania
- An Internet-based Program to Help Cancer Survivors Manage Pain — Fort Smith, Arkansas
- Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors — Toronto, Ontario
- Researching the Effect of Aerobic Exercise on Cancer — Los Angeles, California
Explore by condition: All Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.